Experience of Modern Premixed Insulin Use in Treatment of Diabetes Mellitus

M.V. Vlasenko, S.V. Litvinova, N.I. Gurina, N.A. Kravchuk, Yu.O. Kryvovyaz


No abstract


International Diabetes Federation. Diabetes and Cardiovascular disease: Time to Act. — Brussels, Belgium: International Diabetes Federation, 2001.

King H., Aubert R.E. & A. Herman W.H. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections // Diabetes Care. — 1998. — 1414-1431.

Niskanen L., Turpeinen A., Penttila I., Uusitupa M.I. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis // Diabetes Care. — 1998. — 21(11). —1861-1869.

Nathan D.M., Buse J.B., Davidson M.B., Heine R.J., Holman R.R., Sherwin R. et al. Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes // Diabetes Care. — 2006. — 29(8). — 1963-1972.

Дедов И.И., Шестакова М.В., Алятов А.С. и др. Проект «Консенсус совета экспертов Российской ассоциации эндокринологов (РАЭ) по инициации и интенсификации сахароснижающей терапии сахарного диабета 2 типа» // Сахарный диабет. — 2011. — № 1. — С. 95-105.

Sorkin J.D., Muller D.C., Fleg J.L., Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature // Diabetes Care. — 2005. — 28(11). — 2626-2632.

Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S. et at. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study // Diabetes Res. Clin. Pract. — 1995. — 28(2). — 103-117.

Shiraiwa T., Kaneto H., Miyatsuka T., Kato К., Yamamoto K., Kawashima A. et at. Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients // Biochem. Biophys. Res. Commun. — 2005. — 336(1). — 339-345.

Levitan E.B., Song Y., Ford E.S., Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies // Arch. Intern. Med. — 2004. — 164(19). — 2147-2155.

Hanefeld M., Cagatay M., Petrowitsch T., Neuser D., Petzinna D., Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies // Eur. Heart. J. — 2004. — 25(1). — 10-16.

Woerle H.J., Neumann C., Zschau S., Tenner S., Irsigler A., Schirra J. et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels // Diabetes. Res. Clin. Pract. — 2007.

Hanefeld M., Koehler C., Schaper F., Fuecker K., Henkel E., Temelkova-Kurktschiev T. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals // Atherosclerosis. — 1999. — 144(1). — 229-235.

Шамхалова М.Ш., Чугунова Л.А., Шестакова М.В. Цели и задачи инсулинотерапии при сахарном диабете типа 2: место готовых смесей инсулина // Consilium Medicum. — 2003. — Т. 5, № 9. — С. 491-494.

Koritkowsky M. When oral agents fail: Practical barriers to starting insulin // Int. J. Obes. Relat. Metab. Disord. — 2002. — 26 (Suppl. 3). — S18-S24.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© "Publishing House "Zaslavsky", 1997-2020


   Seo анализ сайта